Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
The Food and Drug Administration is changing its policy to make it easier for gay men to donate blood.
Blue Origin is sending an all-female crew into orbit next year, according to The Wall Street Journal.
Jeff Bezos' girlfriend is leading an all-female space mission aboard a Blue Origin spacecraft.
The Food and Drug Administration is raising concerns about the long-term effects of CBD.
CVS and Walmart are cutting back pharmacy hours due to a shortage of pharmacists.
The U.S. plans to make it easier for gay and bisexual men to give blood by easing restrictions on groups that typically face higher risks of HIV.
Five former Memphis police officers were charged with murder in the death of Tyre Nichols, the FDA explores yearly COVID vaccines, and New York City explores electric Uber and Lyft rides. Here is everything you Need2Know for Friday, January 27, 2023.
The Food and Drug Administration is joining an international probe that is taking a closer look at some cough syrups that have killed over 300 children worldwide.
Payam Banazadeh, founder and CEO of Capella Space, joined Cheddar News to discuss the satellite imagery company's latest $60 million funding and what government projects lie ahead.
Ants could be the next line of defense against cancer, according to a study.
